May 20, 2020 / 02:30PM GMT
David J. Woodhouse - NGM Biopharmaceuticals, Inc. - CEO, Acting CFO & Director
Good morning. My name is David Woodhouse, and I'm the Chief Executive Officer of NGM Biopharmaceuticals, Inc. It is my pleasure to welcome you to the NGM Biopharmaceuticals 2020 Annual Meeting of Stockholders.
The meeting will now officially come to order. The time is now 7:33 a.m. Pacific Time on Wednesday, May 20, 2020, and the polls are now open for voting on all matters to be presented. As you know, we are hosting today's meeting through a virtual online platform hosted by Lumi. This meeting is being recorded and will be archived for 1 year after the date of the annual meeting at web.lumiagm.com/219866537.
Before we proceed with the formal business of the meeting, I'd like to introduce to you the members of the Board and the business team who are with us today. We have William Rieflin, our Executive Chairman; Jin-Long Chen, our Founder and Chief Scientific Officer; David Goeddel; Shelly Guyer; Suzanne Hooper; David Schnell; and Mac Tichenor or McHenry Tichenor. The other members of the business team
NGM Biopharmaceuticals Inc Annual Shareholders Meeting Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers